Molecular Insight Pharmaceuticals, Inc. has completed the purchase of a commercial-scale radiopharmaceutical manufacturing facility in Denton, TX. The company purchased the facility from NeoRx Manufacturing Group, Inc., a subsidiary of Poniard Pharmaceuticals, for $3 million. The facility provides more than 80,000 sq. ft. of pharmaceutical manufacturing, warehouse, clean room and administrative office space. “We are extremely pleased to complete this important strategic acquisition as...